Usefulness of Triphasic Perfusion Computed Tomography for Intravenous Thrombolysis With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke

Authors:
  • SLSoo Joo Lee
    Soo Joo Lee
  • SCSoo-Jin Cho
    Soo-Jin Cho
  • DNDong Gyu Na
    Dong Gyu Na
  • HBHong Sik Byun
    Hong Sik Byun
  • YKYong-Beom Kim
    Yong-Beom Kim
  • HSHee-Jeong Song
    Hee-Jeong Song
  • IJIn-Seon Jin
    In-Seon Jin
  • CCChin-Sang Chung
    Chin-Sang Chung

Abstract
COMPUTED tomography (CT) is widely used in patients with acute ischemic stroke to exclude acute hemorrhage or other diseases mimicking ischemia (tumor and subdural hematoma) when antithrombotic therapy is considered. Perfusion deficit and collateral blood flow are the important factors associated with the safety and efficacy of thrombolytic therapy for acute middle cerebral artery (MCA) stroke.1-3 The risk of hemorrhagic transformation after recanalization of the occluded arteries by thrombolytic therapy is considered high when pretherapeutic residual cerebral blood flow is markedly reduced.4,5 However, precontrast CT cannot provide enough information about perfusion deficit and collateral circulation.